# FDA Inspection 1301534 - Axsome Therapeutics, Inc. - February 06, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/axsome-therapeutics-inc/d755cc61-e3b0-4906-a414-dc235848df39/
Source feed: FDA_Inspections

> FDA Inspection 1301534 for Axsome Therapeutics, Inc. on February 06, 2026. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1301534
- Company Name: Axsome Therapeutics, Inc.
- Inspection Date: 2026-02-06
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Office Name: New York District Office

## Related Documents

- [FDA Inspection 1301534 - 2026-02-06](https://www.globalkeysolutions.net/api/records/fda_inspections/axsome-therapeutics-inc/d46651f4-2c39-47fd-a08e-296c5f14a724/)
- [FDA Inspection 1146168 - 2021-07-01](https://www.globalkeysolutions.net/api/records/fda_inspections/axsome-therapeutics-inc/92b9c333-ffe1-482a-b838-0efdf1775247/)

Company: https://www.globalkeysolutions.net/companies/axsome-therapeutics-inc/0bc3d1e2-dfe0-47ba-b144-4248f1fdfdf0

Office: https://www.globalkeysolutions.net/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d